Autoimmune disorder treatment using RXR agonists
US11576881B2 · kind B2 · utility
0Cited by
73References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 22, 2021 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Dec 22, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present specification provides RXR agonist compounds, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection as well as use of such RXR agonists to manufacture a medicament and use of such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.